Herceptin (trastuzumab) is a targeted therapy used to treat HER2-positive breast and gastric cancers. It works by binding to the HER2 receptors on cancer cells, inhibiting their growth and signaling the immune system to destroy them. This treatment is particularly effective for cancers that overexpress the HER2 protein.